Veracity Capital LLC

Position in CYTK — Cytokinetics Inc

CIK 1811005 Atlanta, GA

Position in CYTK

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$632,024

+$143,368 QoQ

Shares Held

7,419

+0.1% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#291

of 477 holders

Holding Since

Mar 2021

21 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Veracity Capital LLC holds $4,096,412 across 2 Biotechnology names. CYTK ranks #2 (15.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	REGN	Regeneron Pharmaceuticals, Inc.	5,556	$3,464,388
2	CYTK	Cytokinetics Inc This page	7,419	$632,024

21 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$632,024	7,419	+0.1%	Shares	Sole	2026-07-13
2026-03-31	$488,656	7,414	0.0%	Shares	Sole	2026-04-09
2025-12-31	$471,085	7,414	0.0%	Shares	Sole	2026-01-29
2025-09-30	$407,473	7,414	0.0%	Shares	Sole	2025-10-08
2025-06-30	$244,958	7,414	0.0%	Shares	Sole	2025-07-09
2025-03-31	$297,968	7,414	0.0%	Shares	Sole	2025-04-10
2024-12-31	$348,754	7,414	0.0%	Shares	Sole	2025-01-17
2024-09-30	$391,459	7,414	0.0%	Shares	Sole	2024-10-18
2024-06-30	$401,690	7,414	-0.2%	Shares	Sole	2024-07-22
2024-03-31	$520,777	7,428	-0.7%	Shares	Sole	2024-04-19
2023-12-31	$624,338	7,478	+0.6%	Shares	Sole	2024-01-22
2023-09-30	$219,005	7,434	-1.0%	Shares	Sole	2023-10-25
2023-06-30	$244,845	7,506	+0.4%	Shares	Sole	2023-07-20
2023-03-31	$263,010	7,474	-0.5%	Shares	Sole	2023-04-06
2022-12-31	$344,016	7,508	+0.1%	Shares	Sole	2023-01-17
2022-09-30	$363,423	7,501	-9.9%	Shares	Sole	2022-10-17
2022-06-30	$326,932	8,321	0.0%	Shares	Sole	2022-07-18
2022-03-31	$306,296	8,321	0.0%	Shares	Sole	2022-04-18
2021-12-31	$379,271	8,321	0.0%	Shares	Sole	2022-01-31
2021-09-30	$297,392	8,321	-14.3%	Shares	Sole	2021-10-13
2021-03-31	$225,970	9,715	—	Shares	Sole	2021-09-10
No filing history on record for this holder in this stock.